Navigation Links
Starion Achieves Worldwide Distribution of Proprietary Tissue Welding Technology

Researchers in South Africa latest to report patient benefits

SUNNYVALE, Calif., Jan. 31 /PRNewswire/ -- Starion Instruments, a leading surgical device company, today announced that it has extended worldwide distribution of its proprietary tissue welding technology. Physicians in North America, Europe, the Middle East, Africa, and Asia now have access to safe, effective and precise instruments for a wide variety of surgical procedures.

Sealing and dividing soft tissue is an essential part of surgery. Unlike conventional products which use indirect forms of energy: ultrasonic or bipolar radio frequency, Starion instruments perform sealing and dividing with direct heat and pressure. Studies have shown that this method minimizes thermal spread, reduces the risk of collateral damage and decreases patient recovery times.

"Surgeons worldwide are demanding technologies that enhance performance, minimize risk and improve patient outcomes," said Kirt Kirtland, president and chief executive officer of Starion Instruments. "We are excited that our products and value proposition have expanded our reach across the globe."

In South Africa, for example, surgeons are using the company's products in a wide variety of cardiology, general surgery, gynecology, and otolaryngology procedures. The next anticipated areas of expansion are China and Japan, where regulatory approvals are pending.

As Starion's influence grows beyond the U.S., leading researchers from Greece to Taiwan are reporting the benefits of tissue welding technology versus other modalities. Most recently, Lance Maron, MBBCh, FCS (SA), from Netcare Parklane Hospital in Johannesburg, South Africa, presented his findings at the 43rd South African National ENT & SAHNOS Congress.

During the Congress, Maron reported that Starion's forceps are easy to use, cause minimal intra-operative blood loss, facilitate complete removal of tonsils resulting in rapid healing and recovery with less post-operative pain and a fast return to normal diet and school/work.

About Starion Instruments

Starion Instruments is dedicated to developing advanced surgical devices that enhance performance, minimize risk and improve patient outcomes. Starion's instruments employ a proprietary Tissue Welding technology that seals and divides soft tissue while minimizing the risk of collateral damage. Known for their effectiveness, reliability and versatility, Starion's products are used by surgeons worldwide for open and endoscopic cardiac, gynecology, general surgery, otolaryngology and urology procedures. For more information, please visit the company's website at

SOURCE Starion Instruments
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Society of Laproendoscopic Surgeons Names Starion Instruments 2007 Innovator of the Year
2. Surface Logix Achieves Objectives With SLx-4090 in Phase 2a Clinical Trial
3. Pharsight Achieves $7.4 Million in Quarterly Revenue
4. Dalton Medicinal Chemistry Partners Achieves Another Milestone in Collaboration with Boehringer Ingelheim (Canada) Ltd.
5. BIAS Achieves Certified Advantage Partner Level in Oracle PartnerNetwork
6. NOLabs AB Achieves Break-Through in Fight Against MRSA-Bacteria
7. Sigma-Aldrich Achieves Double Accreditation as a Certified Reference Material Producer Following ISO/IEC 17025 and ISO Guide 34
8. BioMS Medical achieves enrollment milestone in U.S. phase III multiple sclerosis trial
9. Dalton Medicinal Chemistry Partners Achieves Milestone in Collaboration with Boehringer Ingelheim (Canada) Ltd.
10. Diplomat Specialty Pharmacy Health Services Division Achieves High Marks in Pilot Program for Chronic Kidney Disease Management
11. Signalife Achieves $1.98 Million Sales Orders Thus Far
Post Your Comments:
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
(Date:6/23/2016)... , June 23, 2016 ... Hematology Review, 2016;12(1):22-8 ... , the peer-reviewed journal from touchONCOLOGY, Andrew ... escalating cost of cancer care is placing an ... result of expensive biologic therapies. With the patents ...
(Date:6/23/2016)... San Francisco, CA (PRWEB) , ... June 23, ... ... capture (EDC) software, is exhibiting at the Pennsylvania Convention Center and will showcase ... DIA Annual conference. ClinCapture will also be presenting a scientific poster on Disrupting ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... a new line of intelligent tools designed, tuned and optimized exclusively for Okuma ... 12–17 in Chicago. The result of a collaboration among several companies with expertise ...
Breaking Biology Technology:
(Date:3/31/2016)... 2016  Genomics firm Nabsys has completed a financial ... Bready , M.D., who returned to the company in ... leadership team, including Chief Technology Officer, John Oliver ... Nurnberg and Vice President of Software and Informatics, ... Dr. Bready served as CEO of Nabsys from ...
(Date:3/23/2016)... , March 23, 2016 ... Interesse erhöhter Sicherheit Gesichts- und Stimmerkennung mit ... Inc. (NASDAQ: MESG ), ein ... dass das Unternehmen mit SpeechPro zusammenarbeitet, um ... der Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, im ...
(Date:3/22/2016)... PROVO and SANDY, ... Screening Ontario (NSO), which operates the highest sample volume ... testing, and Tute Genomics and UNIConnect, leaders in clinical ... today announced the launch of a project to establish ... testing panel. NSO has been contracted ...
Breaking Biology News(10 mins):